MENU
Aim higher

DELTAMET

A novel diagnostic assay to stratify lung cancer patients with EGFR therapy resistance.

Start date: 
01-10-2015
Project Duration: 
39months
Technological Area: 
Diagnostics, Diagnosis
Market Area: 
Diagnostic test products and equipment